文献速递肝病

增强脑膜淋巴引流改善肝硬化大鼠肝性脑病

Enhanced Meningeal Lymphatic Drainage Ameliorates Neuroinflammation and Hepatic Encephalopathy in Cirrhotic Rats.
PubMed 文献 · Gastroenterology · 2020-11-20

研究探讨脑膜淋巴系统在肝性脑病中的作用,采用胆管结扎4周肝硬化HE大鼠模型,经枕大池注射AAV8-VEGF-C促进脑膜淋巴管生成。结果显示增强脑膜淋巴引流可减轻神经炎症并改善运动功能,提示或为HE新治疗策略。

要点

  • 肝硬化HE大鼠皮质小胶质细胞活化及神经炎症因子表达增加
  • AAV8-VEGF-C促进脑膜淋巴管生成和示踪剂引流
  • 增强脑膜淋巴引流减轻神经炎症并改善运动功能障碍

核心结论

  • 促进脑膜淋巴引流和增强废物清除可改善肝性脑病。
  • 调控脑膜淋巴管生成可能是治疗肝性脑病的新策略。

研究设计与样本

  • 采用4周胆管结扎模型建立肝硬化伴肝性脑病大鼠。
  • 通过枕大池注射AAV8-VEGF-C诱导脑膜淋巴管生成。
  • 利用存档GSE41919评估肝性脑病患者脑部炎症。
  • 采用转棒实验评估大鼠运动功能。

主要发现

  • 肝硬化HE大鼠皮质中间区域小胶质细胞活化显著增加(P < .001)。
  • HE大鼠至少一个皮质区域的IL-1β、IFN-γ、TNF-α和Iba1表达显著增加。
  • HE大鼠运动功能受损(P < .05)。
  • 肝硬化HE患者脑组织促炎基因NFKB1、Iba1、TNF-α和IL1β上调(n = 6)。
  • AAV8-VEGF-C注射显著增加脑膜淋巴管生成(P = .035)。

关键数值与推荐

  • AAV8-VEGF-C增加皮质前部和中部示踪剂摄取(P = .006和.003)。
  • AAV8-VEGF-C增加相应脑膜示踪剂摄取(P = .086和.006)。
  • AAV8-VEGF-C增加引流淋巴结示踪剂摄取(P = .02)。
  • AAV8-VEGF-C减少小胶质细胞活化(P < .001)并改善运动功能障碍(P = .024)。

临床怎么用

  • 脑膜淋巴引流可作为肝性脑病潜在干预靶点。
  • 调控脑膜淋巴管生成可能改善神经炎症和运动功能。

局限性

  • 证据主要来自胆管结扎肝硬化大鼠模型。
  • 人类数据基于存档GSE41919且样本量有限(n = 6)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Hepatic encephalopathy (HE) is a serious neurologic complication in patients with liver cirrhosis. Very little is known about the role of the meningeal lymphatic system in HE. We tested our hypothesis that enhancement of meningeal lymphatic drainage could decrease neuroinflammation and ameliorate HE. METHODS: A 4-week bile duct ligation model was used to develop cirrhosis with HE in rats. Brain inflammation in patients with HE was evaluated by using archived GSE41919. The motor function of rats was assessed by the rotarod test. Adeno-associated virus 8-vascular endothelial growth factor C (AAV8-VEGF-C) was injected into the cisterna magna of HE rats 1 day after surgery to induce meningeal lymphangiogenesis. RESULTS: Cirrhotic rats with HE showed significantly increased microglia activation in the middle region of the cortex (P < .001) as well as increased neuroinflammation, as indicated by significant increases in interleukin 1β, interferon γ, tumor necrosis factor α, and ionized calcium binding adaptor molecule 1 (Iba1) expression levels in at least 1 of the 3 regions of the cortex. Motor function was also impaired in rats with HE (P < .05). Human brains of patients with cirrhosis with HE also exhibited up-regulation of proinflammatory genes (NFKB1, IbA1, TNF-α, and IL1β) (n = 6). AAV8-VEGF-C injection significantly increased meningeal lymphangiogenesis (P = .035) and tracer dye uptake in the anterior and middle regions of the cortex (P = .006 and .003, respectively), their corresponding meninges (P = .086 and .006, respectively), and the draining lymph nodes (P = .02). Furthermore, AAV8-VEGF-C decreased microglia activation (P < .001) and neuroinflammation and ameliorated motor dysfunction (P = .024). CONCLUSIONS: Promoting meningeal lymphatic drainage and enhancing waste clearance improves HE. Manipulation of meningeal lymphangiogenesis could be a new therapeutic strategy for the treatment of HE.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Hsu SJ, Zhang C, Jeong J, et al. Enhanced Meningeal Lymphatic Drainage Ameliorates Neuroinflammation and Hepatic Encephalopathy in Cirrhotic Rats. Gastroenterology. 2020. PMID: 33227282. doi:10.1053/j.gastro.2020.11.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。